Assenagon Asset Management S.A. grew its stake in Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 11.2% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 2,729,988 shares of the semiconductor company's stock after purchasing an additional 274,586 shares during the period. Synopsys makes up about 0.9% of Assenagon Asset Management S.A.'s holdings, making the stock its 17th largest holding. Assenagon Asset Management S.A. owned approximately 1.42% of Synopsys worth $1,187,381,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other large investors have also made changes to their positions in SNPS. BlackRock Inc. purchased a new stake in shares of Synopsys in the second quarter valued at about $7,228,099,000. Van ECK Associates Corp raised its stake in Synopsys by 19.7% during the second quarter. Van ECK Associates Corp now owns 3,457,249 shares of the semiconductor company's stock worth $1,542,175,000 after purchasing an additional 569,687 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in Synopsys by 40.7% during the second quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 3,087,349 shares of the semiconductor company's stock worth $1,377,174,000 after purchasing an additional 892,736 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd. acquired a new position in Synopsys in the 2nd quarter valued at about $747,400,000. Finally, Amundi boosted its holdings in Synopsys by 3.6% in the 1st quarter. Amundi now owns 1,761,983 shares of the semiconductor company's stock valued at $698,591,000 after purchasing an additional 61,077 shares during the last quarter. 85.47% of the stock is currently owned by hedge funds and other institutional investors.
Synopsys Trading Down 2.5%
Shares of SNPS stock opened at $468.11 on Friday. Synopsys, Inc. has a fifty-two week low of $362.55 and a fifty-two week high of $539.48. The company has a 50 day moving average price of $426.79 and a 200 day moving average price of $441.42. The stock has a market capitalization of $89.71 billion, a P/E ratio of 82.71, a price-to-earnings-growth ratio of 1.96 and a beta of 1.21. The company has a debt-to-equity ratio of 0.29, a quick ratio of 1.24 and a current ratio of 1.34.
Synopsys (NASDAQ:SNPS - Get Free Report) last released its earnings results on Wednesday, August 26th. The semiconductor company reported $3.91 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $3.67 by $0.24. Synopsys had a net margin of 11.43% and a return on equity of 6.24%. The company had revenue of $2.48 billion for the quarter, compared to analyst estimates of $2.44 billion. During the same period in the prior year, the business earned $3.39 EPS. The firm's quarterly revenue was up 42.4% on a year-over-year basis. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. Equities research analysts predict that Synopsys, Inc. will post 10.97 EPS for the current fiscal year.
Synopsys announced that its Board of Directors has authorized a share repurchase plan on Monday, October 5th that authorizes the company to repurchase $1.00 billion in shares. This repurchase authorization authorizes the semiconductor company to buy up to 1.1% of its shares through open market purchases. Share repurchase plans are usually a sign that the company's board of directors believes its stock is undervalued.
Insiders Place Their Bets
In related news, CEO Sassine Ghazi sold 14,604 shares of the company's stock in a transaction that occurred on Tuesday, September 15th. The stock was sold at an average price of $374.88, for a total value of $5,474,747.52. Following the completion of the transaction, the chief executive officer directly owned 76,865 shares of the company's stock, valued at $28,815,151.20. This represents a 15.97% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Sudhindra Kankanwadi sold 9,170 shares of the business's stock in a transaction that occurred on Tuesday, October 6th. The stock was sold at an average price of $500.00, for a total transaction of $4,585,000.00. Following the sale, the chief financial officer owned 22,717 shares of the company's stock, valued at $11,358,500. This represents a 28.76% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 102,559 shares of company stock valued at $44,607,141 over the last quarter. Corporate insiders own 0.56% of the company's stock.
Wall Street Analysts Forecast Growth
Several research firms have recently commented on SNPS. BNP Paribas Exane lifted their price target on shares of Synopsys from $420.00 to $475.00 and gave the company a "neutral" rating in a research report on Thursday, October 1st. KeyCorp increased their price objective on Synopsys from $600.00 to $605.00 and gave the stock an "overweight" rating in a research report on Thursday, October 1st. Roth Capital raised Synopsys to a "buy" rating in a research note on Friday, September 25th. JPMorgan Chase & Co. reduced their target price on Synopsys from $650.00 to $600.00 in a research report on Thursday, August 27th. Finally, Wells Fargo & Company lifted their target price on Synopsys from $475.00 to $540.00 and gave the company an "overweight" rating in a research report on Thursday, October 1st. One investment analyst has rated the stock with a Strong Buy rating, twenty-one have issued a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $571.78.
Get Our Latest Stock Report on SNPS
Synopsys Profile
(
Free Report)
Synopsys, Inc is a technology company that develops electronic design automation (EDA) software, semiconductor intellectual property (IP), and software tools used to design, verify, and manufacture advanced electronic systems. Its solutions support the development of semiconductors, systems-on-chip, and electronic products across the design cycle, from initial specification and architecture through testing and production.
The company's offerings include digital and custom integrated-circuit design tools, simulation and verification software, physical design and signoff products, and semiconductor IP such as processor cores, interface technologies, and foundational components.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.